Story perspectives

$2.6 Million Boost for Safer Childhood Cancer Treatments

9/6/2025

Summary

Story summary

Victoria, Australia, is allocating $2.6 million to two research teams in the Children’s Cancer CoLab’s Safer Therapies Program.
Associate Professor Rachel Conyers and Professor Mark Dawson aim to reduce toxic side effects in treatments like chemotherapy.
The MONALISA initiative uses liquid biopsies for early neuroblastoma relapse detection, providing a less invasive monitoring method.
This international trial spans 11 countries, integrating digital tools and emotional support for families.
Future efforts will focus on integrating these innovations into national healthcare systems and securing insurance coverage.

History

Historical Context

In 2001, the U.S. National Cancer Institute initiated the Cancer Biomarkers Study to enhance cancer detection and treatment. This led to advancements in liquid biopsy technologies, reducing invasive procedures by over 50%. Current efforts in Victoria, Australia, align with global trends toward less toxic therapies, exemplified by the MONALISA initiative focusing on neuroblastoma, aiming to improve patient care and outcomes.

1 of 2

Story summary

Victoria, Australia, is allocating $2.6 million to two research teams in the Children’s Cancer CoLab’s Safer Therapies Program.
Associate Professor Rachel Conyers and Professor Mark Dawson aim to reduce toxic side effects in treatments like chemotherapy.
The MONALISA initiative uses liquid biopsies for early neuroblastoma relapse detection, providing a less invasive monitoring method.
This international trial spans 11 countries, integrating digital tools and emotional support for families.
Future efforts will focus on integrating these innovations into national healthcare systems and securing insurance coverage.

1 / 2